Global Antithrombotic Drugs Market Will Grow by $17 Billion Over the Next 6 Years, BCC Research Forecasts
global antithrombotic/anticoagulant drugs market, valued at $29 billion in 2022, will reach $46 billion by 2028, BCC analysts project. The market’s expected CAGR between 2023 and 2028 is 7.9%
October 25, 2023
Innovative therapeutics and patient-centric solutions serve aging populations amidst increasing thrombosis prevention awareness.
Boston: The global antithrombotic/anticoagulant drugs market, valued at $29 billion in 2022, will reach $46 billion by 2028, BCC analysts project. The market’s expected CAGR between 2023 and 2028 is 7.9%. Market growth drivers include increased need for the drugs as obesity rates surge around the globe.
To keep up with the increasing demand, global pharmaceutical companies such as Bristol Myers Squibb, Johnson & Johnson, and Sanofi have led research and development and have invested heavily in low-molecular weight heparin (LMWH) anticoagulant drugs.
The report, Global Antithrombotic/Anticoagulant Drug Market, gives detailed insights into diverse categories of antithrombotic medications, including thrombin inhibitors, anticoagulants, and antiplatelets.
The report also explores:
-
Antithrombotics market growth by region: While North America holds the highest share of the market, there has been lots of activity among antithrombotic drug manufacturers in China, India, Brazil and Indonesia.
-
Market trends and forecasts: Thrombin inhibitors are expected to dominate the global antithrombotic market by the end of 2028.
-
M&A activity: The report explores the increase in mergers and acquisitions over the last 5 years and its impacts.
Thrombotic diseases, peripheral vascular diseases, valvular heart diseases, and other cardiovascular diseases are, together, the leading cause of death worldwide. Download Global Antithrombotic/Anticoagulant Drug Market to get the lowdown on therapeutic forecasts for the next five years.
For further information or to make a purchase, please get in touch with info@bccresearch.com.
Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets( PHM119C )
Publish Date: Oct 2023
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Pharmaceuticals
- Cancer Therapeutics Market Forecast to Reach $168 Billion by 2029, Highlighting Recurrent and Metastatic Innovations
- Global Cancer Immunotherapy Market Projected to Reach $247 Billion by 2029, Driven by 11.4% CAGR
- Liver Disease Treatments: Global Market Forecast and Emerging Trends Through 2030
- Radiopharmaceuticals Market Set to Grow with 16.4% CAGR from 2024 to 2029
- Nanotechnology in Cancer Treatment Market Positioned for Transformational Growth by 2029
Reports from Pharmaceuticals
- Global Markets for Infectious Disease Treatments
- Disease-Modifying Therapies for Alzheimer’s Disease: Global Markets
- Global Markets for Allergy Diagnostics and Treatments
- Over-the-Counter (OTC) Drugs, and Vitamins & Dietary Supplements: Global Markets
- Global Pharmaceutical Drugs Industry: Competitive Landscape 2023
Recent News
- BCC Research Releases 2024 Protein Synthesis Research Review
- Global Industrial Enzyme Markets: Innovation, Impact, and Growth
- DNA and RNA Sequencing Markets Set for Rapid Expansion, Says BCC Research
- Emerging Clinical Trial Infrastructure in the MENA Region: A Comprehensive Market Analysis
- Global Market for Media, Sera, and Reagents in Biotechnology to Reach $9.3 Billion by 2029
